Asthma

An analysis found that patients with uncontrolled severe asthma have a higher symptom burden compared with those whose severe asthma is controlled, highlighting the need for more innovative treatment options to improve asthma control.

Data included in this analysis are from the Respiratory Health in Northern Europe study, and they include asthma status, asthma-like symptoms, and other respiratory symptoms.

A recent study found that depressive symptoms improved among patients with severe asthma who responded to monoclonal antibody (mAb) therapy, but baseline depression symptoms were associated with lower therapy response rates.

Multiple risk factors for uncontrolled asthma include racial and ethnic barriers, as well as health insurance status, according to one study.

Higher baseline blood eosinophil count was linked to improvement in asthma exacerbations and overall better outcomes seen with biologic therapies.

Women and children are the most susceptible to adverse asthma outcomes due to climate change, according to one study.

A new study found that adolescents with short-term exclusive cigarette use had a higher risk of incident asthma after 5 years of follow-up.

The prevalence of high metabolism scores for visceral fat, especially among sensitive populations, may be associated with a heightened asthma risk, according to one study.

Children with severe asthma who moved to better-resourced neighborhoods in Baltimore showed improvement of symptoms, according to a recent study.

Health systems participating in the drug discount program did not have fewer disparities than hospitals not participating.

Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma are type 2 inflammatory conditions that frequently coexist, the with the latter increasing the symptom burden of the former

A positive association between asthma and overall cancer risk was found, according to this new study.

The study examined the prevalence of prescription medications in jails and state prisons for individuals with chronic conditions, such as asthma, type 2 diabetes, hypertension, hepatitis B and C, HIV infection, depression, and severe mental illness, compared with the general population.

Individuals with severe type 2 asthma and chronic rhinosinusitis with nasal polyps may benefit from the biologic treatment, dupilumab.

Sleep and genetics play individual roles in increasing a person’s risk for asthma, but their combination also heightens that risk.

Researchers compared the effectiveness of 3 biologics for moderate to severe asthma in an observational study and found superior improvement with dupilumab.

Children born preterm are more likely to have respiratory symptoms at least up to middle age, according to one study.

Rates of asthma diagnoses declined at the beginning at the pandemic compared with rates of new diagnoses in the previous 3 years, according to one study.

Pollen may contribute to an increased risk of asthma attacks and asthma-related emergency visits, according to one study.

Research suggests allergic diseases may increase risk of osteoarthritis (OA), for which there is currently no effective cure.

Dupilumab is the first biologic to significantly improve lung function in chronic obstructive pulmonary disease (COPD), according to topline results released Thursday.

Age-specific risk factors for asthma-like symptoms were identified in the first, second, and third years of life, a new study finds.

The combination of smoking and socioeconomic status (SES) is associated with risk of asthma among different socio-occupational groups, this new study found.

Abstracts presented at the American Academy of Allergy, Asthma & Immunology conference examined how ethnic and language barriers in respiratory care affect Hispanic patients, with results showing the need for improved asthma care.

How asthma and other skin conditions cluster in Black children and a finding of increased risk of respiratory infections in Black and Mexican-American children with asthma were among the studies presented at the American Academy of Allergy, Asthma, and Immunology (AAAAI) conference.